The finding of higher levels of IFN-γ responses in TNFi-treated patients with IBD 3 and 6 months after 2-dose vaccination was maintained when mRNA-1273–vaccinated donors were excluded from the analysis (Supplemental Figure 2, B and C). This evidence concerns the gene IFNG and inflammatory bowel disease.